Characterization of panel antibodies for classification of cancer type using novel antibody-based phosphoproteomics

1 Department of Human Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan 2 Department of Clinical Laboratory Medicine, Faculty of Health Science Technology, Bunkyo Gakuin University, Tokyo, Japan 3 Department of Pathology, Shuuwa General Hospital, Saitama, Japan 4 Department of Physics, School of Science, Kitasato University, Kanagawa, Japan

[1]  Yong-Chen Lu,et al.  Cancer immunotherapy targeting neoantigens. , 2016, Seminars in immunology.

[2]  J. Weon,et al.  The MAGE protein family and cancer. , 2015, Current opinion in cell biology.

[3]  M. Koike,et al.  Potential of classification of cancer by multiple discriminant analysis for relationship between cancer and expression of human cellular phosphoprotein. , 2012, Biomedical research.

[4]  R. Roden,et al.  Antigen‐specific immunotherapy of cervical and ovarian cancer , 2008, Immunological reviews.

[5]  S. Tsukita,et al.  Functional involvement of TMF/ARA160 in Rab6-dependent retrograde membrane traffic. , 2007, Experimental cell research.

[6]  K. Yamaguchi,et al.  Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  L. Meisner,et al.  Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein. , 2000, Cancer research.

[8]  Xuan Peng,et al.  A Novel Cytoplasmic Protein with RNA-binding Motifs Is an Autoantigen in Human Hepatocellular Carcinoma , 1999, The Journal of experimental medicine.

[9]  Lloyd J. Old,et al.  A Survey of the Humoral Immune Response of Cancer Patients to a Panel of Human Tumor Antigens , 1998, The Journal of experimental medicine.

[10]  S. Ménard,et al.  High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  S. Ohwada,et al.  Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions , 1997, Cellular and Molecular Life Sciences CMLS.

[12]  J. Sidney,et al.  Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells. , 1997, Journal of immunology.

[13]  K. Kawahara,et al.  Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer. , 1996, Chest.

[14]  A. Houghton.  Cancer antigens: immune recognition of self and altered self , 1994, The Journal of experimental medicine.

[15]  T. Yip,et al.  New desorption strategies for the mass spectrometric analysis of macromolecules , 1993 .

[16]  M. Hayami,et al.  Production and characterization of mouse monoclonal antibodies against the transmembrane protein of a human immunodeficiency virus type 2. , 1991, AIDS research and human retroviruses.

[17]  Sawada Jun-ichi,et al.  Molecular characterization of monoclonal anti-steroid antibodies : primary structures of the variable regions of seven antibodies specific for 17α-hydroxyprogesterone or 11-deoxycortisol and their pH-reactivity profiles , 1991 .

[18]  M. Hayami,et al.  Multiple antigenic epitopes expressed on gag proteins, p26 and p15, of a human immunodeficiency virus (HIV) type 2 as defined with a library of monoclonal antibodies. , 1990, AIDS research and human retroviruses.

[19]  N. Nomura,et al.  Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. , 1988, Oncogene.

[20]  T. Yamane,et al.  Hormonal Control of α-Fetoprotein Secretion in Human Hepatoma Cell Lines Proliferating in Chemically Defined Medium , 1985 .

[21]  S. Hirohashi,et al.  Monoclonal antibody reactive with the sialyl-sugar residue of a high molecular weight glycoprotein in sera of cancer patients. , 1984, Gan.

[22]  S. Matsuno,et al.  Establishment of a human pancreatic cancer cell line and detection of pancreatic cancer associated antigen. , 1984, The Tohoku journal of experimental medicine.

[23]  G. Murphy,et al.  LNCaP model of human prostatic carcinoma. , 1983, Cancer research.

[24]  D. Pim,et al.  Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer , 1982, International journal of cancer.

[25]  Ivan Damjanov,et al.  Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line , 1979, Nature.

[26]  D. Dexter,et al.  N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. , 1979, Cancer research.

[27]  G. Moore,et al.  Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. , 1978, Cancer research.

[28]  D. Paulson,et al.  Isolation of a human prostate carcinoma cell line (DU 145) , 1978, International journal of cancer.

[29]  K. Sakakibara,et al.  Establishment of cultured cell lines derived from a human gastric carcinoma. , 1978, The Japanese journal of experimental medicine.

[30]  D. Sutherland,et al.  Human Pancreatic Transplantation , 1978, Diabetes Care.

[31]  A. Yunis,et al.  Human pancreatic carcinoma (mia paca‐2) in continuous culture: Sensitivity to asparaginase , 1977, International journal of cancer.

[32]  B Drewinko,et al.  Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. , 1976, Cancer research.

[33]  Barry H. Smith,et al.  A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.

[34]  M. Lieber,et al.  Establishment of a continuous tumor‐cell line (PANC‐1) from a human carcinoma of the exocrine pancreas , 1975, International journal of cancer.

[35]  J. Minowada,et al.  Terminal deoxynucleotidyl transferase activity in a cell line (molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia. , 1973, Biochemical and biophysical research communications.

[36]  R. W. Baldwin.  Tumour‐specific immunity against spontneous rat tumours , 1966, International journal of cancer.

[37]  J. Sawada,et al.  Molecular characterization of monoclonal anti-steroid antibodies: primary structures of the variable regions of seven antibodies specific for 17 alpha-hydroxyprogesterone or 11-deoxycortisol and their pH-reactivity profiles. , 1991, Molecular immunology.

[38]  T. Yamane,et al.  Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium. , 1985, Cancer research.